CXCL12ε



CXCL12ε

K1KK1P2PP2V3VV3S4SS4L5LL5S6SS6Y7YY7R8RR8C9CC9P10PP10C11CC11R12RR12F13FF13F14FF14E15EE15S16SS16H17HH17V18VV18A19AA19R20RR20A21AA21N22NN22V23VV23K24KK24H25HH25L26LL26K27KK27I28II28L29LL29N30NN30T31TT31P32PP32N33NN33C34CC34A35AA35L36LL36Q37QQ37I38II38V39VV39A40AA40R41RR41L42LL42K43KK43N44NN44N45NN45N46NN46R47RR47... and 22 more residue(s)...... and 22 more residue(s)

SMILES None
InChIKey None
Sequence KPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNNC

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

CXCL12ε

K1KK1P2PP2V3VV3S4SS4L5LL5S6SS6Y7YY7R8RR8C9CC9P10PP10C11CC11R12RR12F13FF13F14FF14E15EE15S16SS16H17HH17V18VV18A19AA19R20RR20A21AA21N22NN22V23VV23K24KK24H25HH25L26LL26K27KK27I28II28L29LL29N30NN30T31TT31P32PP32N33NN33C34CC34A35AA35L36LL36Q37QQ37I38II38V39VV39A40AA40R41RR41L42LL42K43KK43N44NN44N45NN45N46NN46R47RR47... and 22 more residue(s)...... and 22 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.